Suzhou Basecare Medical Corporation Limited (HKG:2170)
2.020
-0.030 (-1.46%)
Jan 21, 2026, 3:42 PM HKT
HKG:2170 Revenue
Suzhou Basecare Medical Corporation had revenue of 101.34M CNY in the half year ending June 30, 2025, with 18.46% growth. This brings the company's revenue in the last twelve months to 275.71M, up 11.55% year-over-year. In the year 2024, Suzhou Basecare Medical Corporation had annual revenue of 299.11M with 43.82% growth.
Revenue (ttm)
275.71M CNY
Revenue Growth
+11.55%
P/S Ratio
1.86
Revenue / Employee
554.74K CNY
Employees
497
Market Cap
560.73M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 299.11M | 91.13M | 43.82% |
| Dec 31, 2023 | 207.98M | 67.08M | 47.60% |
| Dec 31, 2022 | 140.90M | 33.60M | 31.32% |
| Dec 31, 2021 | 107.30M | 26.19M | 32.29% |
| Dec 31, 2020 | 81.11M | 25.42M | 45.66% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| JD Health International | 71.34B |
| BeOne Medicines AG | 38.69B |
| Alibaba Health Information Technology | 36.09B |
| Sino Biopharmaceutical | 33.49B |
| CSPC Pharmaceutical Group | 28.65B |
| WuXi Biologics | 21.98B |
| Hansoh Pharmaceutical Group Company | 14.45B |
| Innovent Biologics | 12.52B |